Niagen Bioscience (NASDAQ:NAGE – Get Free Report) and Edgewell Personal Care (NYSE:EPC – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.
Institutional & Insider Ownership
15.4% of Niagen Bioscience shares are owned by institutional investors. Comparatively, 91.9% of Edgewell Personal Care shares are owned by institutional investors. 10.0% of Niagen Bioscience shares are owned by insiders. Comparatively, 3.0% of Edgewell Personal Care shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Profitability
This table compares Niagen Bioscience and Edgewell Personal Care’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Niagen Bioscience | 8.37% | 10.26% | 7.57% |
| Edgewell Personal Care | -4.55% | 5.76% | 2.35% |
Analyst Recommendations
This is a summary of recent ratings and target prices for Niagen Bioscience and Edgewell Personal Care, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Niagen Bioscience | 0 | 1 | 4 | 1 | 3.00 |
| Edgewell Personal Care | 1 | 4 | 3 | 0 | 2.25 |
Niagen Bioscience presently has a consensus price target of $8.50, indicating a potential upside of 287.24%. Edgewell Personal Care has a consensus price target of $31.50, indicating a potential upside of 7.62%. Given Niagen Bioscience’s stronger consensus rating and higher probable upside, equities analysts plainly believe Niagen Bioscience is more favorable than Edgewell Personal Care.
Earnings and Valuation
This table compares Niagen Bioscience and Edgewell Personal Care”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Niagen Bioscience | $129.42 million | 1.35 | $17.38 million | $0.12 | 18.29 |
| Edgewell Personal Care | $2.22 billion | 0.61 | $25.40 million | ($2.00) | -14.64 |
Edgewell Personal Care has higher revenue and earnings than Niagen Bioscience. Edgewell Personal Care is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Niagen Bioscience has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500. Comparatively, Edgewell Personal Care has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500.
Summary
Niagen Bioscience beats Edgewell Personal Care on 12 of the 15 factors compared between the two stocks.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
About Edgewell Personal Care
Edgewell Personal Care Company is a manufacturer and marketer of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. As of September 30, 2016, the Company had a portfolio of over 25 brands. It manages its business in four segments: Wet Shave, Sun and Skin Care, Feminine Care and All Other. Its Wet shave products are sold under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard and Personna brand names. Its Sun and Skin Care products are sold under the Banana Boat, Hawaiian Tropic, Wet Ones and Playtex brand names and offers Wet Ones, portable hand wipes category, and Playtex household gloves, the branded household glove in the United States. Its Feminine Care segment markets its products under the Playtex, Stayfree, Carefree and o.b. brands and markets pads and liners. Its All Other segment includes infant care, pet care and miscellaneous other products.
Receive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
